NEO

NeoGenomics (NEO)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NEO
DataOraFonteTitoloSimboloCompagnia
30/04/202413:30Business WireNeoGenomics Reports First Quarter 2024 ResultsNASDAQ:NEONeoGenomics Inc
18/04/202413:05Business WireNeoGenomics Announces Senior Leadership PromotionsNASDAQ:NEONeoGenomics Inc
09/04/202413:00Business WireNeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NEONeoGenomics Inc
27/03/202413:30Business WireNeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual MeetingNASDAQ:NEONeoGenomics Inc
20/03/202412:00Business WireNeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) ReportNASDAQ:NEONeoGenomics Inc
06/03/202422:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/03/202423:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NEONeoGenomics Inc
01/03/202413:05Business WireNeoGenomics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:NEONeoGenomics Inc
26/02/202422:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NEONeoGenomics Inc
20/02/202422:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NEONeoGenomics Inc
20/02/202422:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NEONeoGenomics Inc
20/02/202422:05Business WireNeoGenomics Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:NEONeoGenomics Inc
20/02/202411:37IH Market NewsMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices DipNASDAQ:NEONeoGenomics Inc
14/02/202416:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NEONeoGenomics Inc
09/02/202421:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NEONeoGenomics Inc
01/02/202413:05Business WireNeoGenomics Signs Working with Cancer Pledge in Support of EmployeesNASDAQ:NEONeoGenomics Inc
30/01/202413:05Business WireNeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024NASDAQ:NEONeoGenomics Inc
02/01/202413:05Business WireNeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:NEONeoGenomics Inc
06/11/202322:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NEONeoGenomics Inc
08/07/202300:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
03/06/202300:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEONeoGenomics Inc
01/06/202322:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NEONeoGenomics Inc
30/05/202322:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NEONeoGenomics Inc
09/05/202322:40Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NEONeoGenomics Inc
07/04/202322:07Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:NEONeoGenomics Inc
07/04/202322:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NEONeoGenomics Inc
07/04/202322:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NEONeoGenomics Inc
22/03/202313:00Business WireMassive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient CareNASDAQ:NEONeoGenomics Inc
24/02/202322:43Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NEONeoGenomics Inc
09/02/202321:43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NEONeoGenomics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NEO

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network